In secondary analysis, comparison between cardiac amyloidosis patients (5 ATTR+5 AL) and 10 age‐matched controls showed similar results, with all differences remaining significant despite a reduction in statistical power (Table S3). The gene discussed is TTR; the disease is cardiac amyloidosis.